Acalabrutinib maleate

Category Pipeline APIs

Details	Specifications
CAS Number	2641500-53-8
Molecular Formula	C26H23N7O2?C4H4O4.H2O
Molecular Weight	599.6 g/mol.
Synonyms	Benzamide,4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl] imidazo[1,5a] pyrazin-1-yl]-N-2-pyridinyl-, (2Z)-2-butenedioate, hydrate
Chemical Name	4-{8-Amino-3-[(2S)-1-(but-2-ynoyl) pyrrolidin-2-yl] imidazo[1,5-a] pyrazin-1-yl}-N-(pyridin-2-yl) benzamide (2Z)-2-butenedioic acid hydrate
Therapeutic use	Mantle Cell Lymphoma (MCL), Chronic lymphocytic leukemia (CLL), Small lymphocytic lymphoma (SLL).
Status	Tech pack available
Background	Acalabrutinib, sold under the brand name Calquence, is a second-generation, small-molecule inhibitor of Bruton's tyrosine kinase (BTK). Developed by Acerta Pharma (now part of AstraZeneca), it was designed to be more selective and potent than earlier BTK inhibitors like ibrutinib.
Grade	In-house
Polymorph	Form-A & Amorphous.
Storage Temperature	Form A: Controlled room temperature (20?C ? 25?C) \| Amorphous: Controlled temperature at 2?C ? 8?C

Please Note: We partner exclusively with pharmaceutical manufacturers, biotech companies, and international trading firms. Minimum order quantities apply*

Disclaimer:

The information provided on this webpage is based on the best available knowledge at the time of publication; however, accuracy and completeness are not guaranteed. Product specifications may change without notice. It is the responsibility of the purchaser or user to verify suitability and compliance. This product is intended for research use only and is not approved for human consumption.

Why Shilpa Pharma?

Happy Customers

Projects Successfully Completed

Established

PhD Experts Driving R&D Excellence

Team Size

World-Class API Manufacturing Sites

Global Audits Successfully Completed

Comprehensive CDMO Service Offerings

Our Acalabrutinib maleate are also Available for

Questions & Answers

FAQ on Acalabrutinib maleate

Everything You Need to Know About Shilpa Pharma

Shilpa Pharma – Your Trusted Global CDMO Partner

Delivering end-to-end solutions across API oncology, generics, peptides, polymers and specialty chemicals, we empower partners to accelerate development, ensure compliance, and reach markets faster with reliable, cost-effective innovation.